Who is sponsoring NCT03173885?

NCT03173885 is sponsored by University Hospital, Ghent.

What drugs are being tested in NCT03173885?

Interventions in NCT03173885: Preimplantation Genetic Screening.

What condition does NCT03173885 study?

NCT03173885 studies Infertility, Preimplantation Genetic Screening.

Is NCT03173885 still recruiting?

NCT03173885 is currently terminated. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT03173885: BIOPS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening

Terminated NA Last updated 19 September 2024

What this trial tests

NA trial testing Preimplantation Genetic Screening in Infertility in 56 participants. Terminated before completion.

Timeline

18 May 2017

Primary endpoint
5 February 2020

5 February 2020

Quick facts

Lead sponsor	University Hospital, Ghent
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	56
Start date	18 May 2017
Primary completion	5 February 2020
Estimated completion	5 February 2020
Sites	1 location across Belgium

Drugs / interventions tested

Preimplantation Genetic Screening

Conditions studied

Infertility — all drugs for Infertility →
Preimplantation Genetic Screening — all drugs for Preimplantation Genetic Screening →

Sponsor

University Hospital, Ghent

Who can join

Adults 18 to 37, female only, with Infertility or Preimplantation Genetic Screening. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a two-arm parallel group randomized controlled trial at the Department of Reproductive Medicine at Ghent University Hospital. Women \>=18 and \<37 years of age undergoing their first or second IVF/ICSI treatment, with at least 2 good quality blastocysts remaining after fresh embryo transfer will be randomized to either transfer of a cryopreserved blastocyst selected based on morphology (standard treatment arm) or transfer of a cryopreserved blastocyst selected based on PGS and morphology (intervention treatment arm).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.
Cornelisse S, Zagers M, Kostova E, Fleischer K, et al · · 2020 · cited 90× · PMID 32898291 · DOI 10.1002/14651858.cd005291.pub3

Verify or expand the search:

Other trials of Preimplantation Genetic Screening

Trials testing the same drug.

NCT06084377 — Isolation of Cell Free Fetal DNA From Spent Culture Medium and Its Potential Role for Preimplantation Genetic Diagnosis · completed

Other recruiting trials for Infertility

Currently open trials in the same condition.

NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting

Other University Hospital, Ghent trials

Trials by the same sponsor.

NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03173885 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03173885.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing